Adrenocortical carcinoma · ISRCTN10535105
STARFISH: A research study to find out whether steroids given by mouth, an injection through the ear drum, or a combination of both treatments is best at improving hearing after unexplained sudden hearing loss.
A randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: The STARFISH Trial
- Status
- recruiting 2023-07-26 to 2027-10-31 (ISRCTN)
- Phase
- Phase III
- Sponsor
- Not stated
- Registry records
- ISRCTN ISRCTN10535105 (recruiting 2023-07-26 to 2027-10-31)Registry last updated 2026-11-03
Eligibility, line by line
| Verdict | In plain words (machine summary) | Registry text, verbatim | If unmet |
|---|---|---|---|
| inclusion inclusion · age sex · confidence 0.97 | Adults aged 18 years or over | "Adults aged 18 years or over" | |
| inclusion inclusion · condition · confidence 0.95 | Diagnosis of new-onset ISSNHL: a new increase in sensorineural thresholds of 30 decibels (dBHL) or greater affecting each of three contiguous pure-tone frequencies (out of 0.5, 1.0, 2.0, 4.0 kilohertz (kHz)) confirmed with a pure tone audiogram, having an onset over a period of 3 days or less according to the patient's history | "Diagnosis of new-onset ISSNHL: a new increase in sensorineural thresholds of 30 decibels (dBHL) or greater affecting each of three contiguous pure-tone frequencies (out of 0.5, 1.0, 2.0, 4.0 kilohertz (kHz)) confirmed with a pure tone audiogram, having an onset over a period of 3 days or less according to the patient's history" | |
| inclusion inclusion · washout · confidence 0.30 | Onset of hearing loss within 4 weeks prior to randomisation | "Onset of hearing loss within 4 weeks prior to randomisation" | |
| inclusion inclusion · logistics · confidence 0.30 | English spoken as a first or second language | "English spoken as a first or second language" | |
| exclusion exclusion · condition · confidence 0.95 | Identified cause for hearing loss (not idiopathic) | "Identified cause for hearing loss (not idiopathic)" | |
| exclusion exclusion · condition · confidence 0.95 | Bilateral ISSNHL | "Bilateral ISSNHL" | |
| exclusion exclusion · prior therapy · confidence 0.95 | Received prior steroid treatment for the same episode of ISSNHL | "Received prior steroid treatment for the same episode of ISSNHL" | |
| exclusion exclusion · comorbidity · confidence 0.90 | Medical contraindication to high dose systemic steroids | "Medical contraindication to high dose systemic steroids" | |
| exclusion exclusion · comorbidity · confidence 0.95 | Previous history of psychosis | "Previous history of psychosis" | |
| exclusion exclusion · prior therapy · confidence 0.95 | On oral steroid therapy for another condition | "On oral steroid therapy for another condition" | |
| exclusion exclusion · comorbidity · confidence 0.95 | Known adrenocortical insufficiency other than exogenous corticosteroid therapy | "Known adrenocortical insufficiency other than exogenous corticosteroid therapy" | |
| exclusion exclusion · comorbidity · confidence 0.95 | Hypersensitivity to the active substance or to any of the excipients | "Hypersensitivity to the active substance or to any of the excipients" | |
| exclusion exclusion · comorbidity · confidence 0.93 | Has a systemic infection unless specific anti-infective therapy is employed | "Has a systemic infection unless specific anti-infective therapy is employed" | |
| exclusion exclusion · comorbidity · confidence 0.95 | Has ocular herpes simplex | "Has ocular herpes simplex" | |
| exclusion exclusion · comorbidity · confidence 0.95 | Has ipsilateral acute or chronic active middle ear disease (including acute otitis media, chronic suppurative otitis media and cholesteatoma, excluding dry perforation) | "Has ipsilateral acute or chronic active middle ear disease (including acute otitis media, chronic suppurative otitis media and cholesteatoma, excluding dry perforation)" | |
| exclusion exclusion · consent · confidence 0.30 | Does not have the capacity to provide written informed consent | "Does not have the capacity to provide written informed consent" |
Criteria extracted by claude-sonnet-5-5; 0 extracted quotes rejected for not matching the registry text.
Full eligibility text as the registry publishes it
Inclusion criteria: Current inclusion criteria as of 13/11/2025: 1. Adults aged 18 years or over 2. Diagnosis of new-onset ISSNHL: a new increase in sensorineural thresholds of 30 decibels (dBHL) or greater affecting each of three contiguous pure-tone frequencies (out of 0.5, 1.0, 2.0, 4.0 kilohertz (kHz)) confirmed with a pure tone audiogram, having an onset over a period of 3 days or less according to the patient's history* 3. Onset of hearing loss within 4 weeks prior to randomisation 4. English spoken as a first or second language *Where audiometry is not available prior to the ISSNHL and there is a history is of equal hearing in both ears prior to the sudden loss, hearing loss will be defined in relation to the opposite ear’s thresholds. Where audiometry is not available prior to the ISSNHL and there is a history of different hearing in both ears prior to the sudden loss, then the candidate can only be included if the ISSNHL occurred in the better hearing ear and the measured thresholds are at least 30dB below the contralateral ear at three contiguous pure-tone frequencies (out of 0.5, 1.0, 2.0, 4.0 kilohertz (kHz)) confirmed with a pure tone audiogram. Previous inclusion criteria: 1. Adults aged 18 years or over 2. Diagnosis of new-onset ISSNHL- sensorineural hearing loss of 30 decibels (dBHL) or greater occurring within a 3-day period and including 3 contiguous pure-tone frequencies (out of 0.5, 1.0, 2.0, 4.0 kilohertz (kHz)) confirmed with a pure tone audiogram occurring within a 3-day period (based on participant-reported history) 3. Onset of hearing loss within 4 weeks prior to randomisation 4. English spoken as a first or second language Exclusion criteria: 1. Identified cause for hearing loss (not idiopathic) 2. Bilateral ISSNHL 3. Received prior steroid treatment for the same episode of ISSNHL 4. Medical contraindication to high dose systemic steroids 5. Previous history of psychosis 6. On oral steroid therapy for another condition 7. Known adrenocortical insufficiency other than exogenous corticosteroid therapy 8. Hypersensitivity to the active substance or to any of the excipients 9. Has a systemic infection unless specific anti-infective therapy is employed 10. Has ocular herpes simplex 11. Has ipsilateral acute or chronic active middle ear disease (including acute otitis media, chronic suppurative otitis media and cholesteatoma, excluding dry perforation) 12. Does not have the capacity to provide written informed consent
Routes in: how this trial is reached and paid for
UK access: residence, not citizenship
Being a British citizen does not by itself entitle you to free NHS treatment; entitlement runs on being ordinarily resident in the UK.
The UK and EU agreed to continue a planned-treatment scheme equivalent to S2 from 1 January 2021, so an S2 issued by an EU insurer is the thing to ask about for a UK trial. Put the question to both your insurer and the trial coordinator, since sponsors sometimes cover trial-related care regardless.
Verify with: NHS: planned treatment abroad and the S2 route
Ask both; not free by citizenship
Free patient navigation
myTomorrows (Amsterdam) provides medically trained, multilingual patient navigators who search ClinicalTrials.gov, EU CTIS and ISRCTN and can support a doctor through an expanded-access application. Free to patients and families.
A navigator keeps searching after any single page stops being current. Use it alongside this site, not instead of your oncologist.
Verify with: myTomorrows for patients
0
Sites (63)
United Kingdom
- Aberdeen Royal Infirmary, Aberdeen
- Addenbrookes, Cambridge
- Broomfield Hospital, Chelmsford
- Charing Cross Hospital, London
- Colchester General Hospital, Colchester
- Countess of Chester Hospital, Chester
- Freeman Road Hospital, Newcastle upon Tyne
- Furness Hospitals NHS Trust, Barrow-in-furness
- West Wales General Hospital, Carmarthen
- Glasgow Royal Infirmary, Glasgow
- Gloucestershire Royal Hospital, Gloucester
- Great Western Hospitals NHS Foundation Trust, Swindon
- and 51 more